We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Alliance Pharma Plc | LSE:APH | London | Ordinary Share | GB0031030819 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
3.35 | 10.60% | 34.95 | 34.65 | 34.70 | 35.10 | 31.00 | 31.00 | 4,048,392 | 16:35:20 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 167.42M | 936k | 0.0017 | 204.12 | 187.43M |
TIDMAPH TIDMAV.
RNS Number : 6866B
Alliance Pharma PLC
05 April 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES ------------------------------------------------------------------------------------------------------------------------ 1. Identity of the issuer or the underlying Alliance Pharma plc issuer of existing shares to which voting rights are attached: -------------------------------------------------------------- -------------------------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------------------------------------------------------ An acquisition or disposal of voting rights ------------------------------------------------------------------ ---------------------------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------------ ---------------------------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------------ ---------------------------------------------------- An event changing the breakdown of voting rights ------------------------------------------------------------------ ---------------------------------------------------- Other (please specify): ---------------------------------------------------------- ------ ---------------------------------------------------- 3. Full name of person(s) subject Aviva plc & its subsidiaries to the notification obligation: ------------------------------------------------------------ ---------------------------------------------------------- 4. Full name of shareholder(s) Registered Holder: (if different from 3.): Available on request 18,450* Chase (GA Group) Nominees Limited 35,223,402* *denotes direct interest Chase Nominees Limited 1,165,093 ------------------------------------------------------------ ---------------------------------------------------------- 5. Date of the transaction and date 3 April 2017 on which the threshold is crossed or reached: ------------------------------------------------------------ ---------------------------------------------------------- 6. Date on which issuer notified: 5 April 2017 ------------------------------------------------------------ ---------------------------------------------------------- 7. Threshold(s) that is/are crossed 8% to 7% Change at Direct Interest or Level (Box 8A) reached: ------------------------------------------------------------ ---------------------------------------------------------- 8. Notified details: -------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares -------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction if possible using the ISIN CODE -------------- --------------------------- ----------------------------------------------------------------- Number Number Number Number of voting % of voting rights of of of shares rights Shares Voting Rights -------------- ------------- ------------ -------------- -------------------------- --------------------- Direct Direct Indirect Direct Indirect -------------- ------------- ------------ -------------- ----------- ------------- -------- ----------- Ordinary Shares GB0031030819 43,574,295* 43,574,295* 36,406,945 35,241,852 1,165,093 7.46% 0.24% ------------- ------------ -------------- ----------- ------------- -------- ----------- * Includes Right to Recall Loaned Shares (108,293) -------------------------------------------------------------------------------------------------------------- B: Qualifying Financial Instruments -------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction -------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion Period rights that may rights instrument be acquired if the instrument is exercised/ converted. -------------- ------------- ---------------------------- -------------------------- --------------------- RIGHT TO RECALL 50,000* LOANED SHARES N/A N/A *Direct Interest 0.01% -------------- ------------- ---------------------------- -------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------- Type of financial Exercise Expiration Exercise/ Number of voting % of voting rights instrument price date Conversion rights instrument period refers to ------------------ --------- ----------- ------------ ------------------- --------------------- Nominal Delta ------------------ --------- ----------- ------------ ------------------- ----------- -------- Total (A+B+C) ------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------ ---------------------------- 36,456,945 7.71% ------------------------ ---------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: -------------------------------------------------------------------------------------------------------------- The voting rights are managed and controlled by Aviva Investors Global Services Limited and Friends Provident International Limited, with the following chain of controlled undertakings:- Aviva Investors Global Services Limited: * Aviva plc (Parent Company) * Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) * Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) * Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited) Friends Provident International Limited: * Aviva plc (Parent Company) * Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) * Friends Provident International Limited (wholly owned subsidiary of Aviva Group Holdings Limited) Proxy Voting: -------------------------------------------------------------------------------------------------------------- 10. Name of the proxy holder: See Section 4 ------------------------------------------------------------- ----------------------------------------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- -----------------------------------------------
12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- ----------------------------------------------- 13. Additional information: Figures are based on a total number of voting rights of 472,716,142, as per the Company's 'Application for admission' announcement of 14(th) February 2017. ------------------------------------------------------------- ----------------------------------------------- 14. Contact name: James Clark, Aviva plc ------------------------------------------------------------- ----------------------------------------------- 15. Contact telephone number: 01603 683853 ------------------------------------------------------------- -----------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAALSEAFXEFF
(END) Dow Jones Newswires
April 05, 2017 08:30 ET (12:30 GMT)
1 Year Alliance Pharma Chart |
1 Month Alliance Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions